These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 22688661)
1. Evaluation of lymphadenectomy in patients receiving neoadjuvant radiotherapy for rectal adenocarcinoma. Le M; Nelson R; Lee W; Mailey B; Duldulao M; Chen YJ; Garcia-Aguilar J; Kim J Ann Surg Oncol; 2012 Nov; 19(12):3713-8. PubMed ID: 22688661 [TBL] [Abstract][Full Text] [Related]
2. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer. Zhan T; Gu J; Li M; Du C Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609 [TBL] [Abstract][Full Text] [Related]
3. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy. Morcos B; Baker B; Al Masri M; Haddad H; Hashem S Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133 [TBL] [Abstract][Full Text] [Related]
4. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. Madbouly KM; Abbas KS; Hussein AM Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666 [TBL] [Abstract][Full Text] [Related]
5. The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma. Solomon N; Zhuge Y; Cheung M; Franceschi D; Koniaris LG Ann Surg Oncol; 2010 Mar; 17(3):791-803. PubMed ID: 19953332 [TBL] [Abstract][Full Text] [Related]
6. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Chang GJ; Rodriguez-Bigas MA; Eng C; Skibber JM Cancer; 2009 Dec; 115(23):5432-40. PubMed ID: 19673001 [TBL] [Abstract][Full Text] [Related]
7. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer. Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464 [TBL] [Abstract][Full Text] [Related]
8. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Mariette C; Piessen G; Briez N; Triboulet JP Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546 [TBL] [Abstract][Full Text] [Related]
9. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809 [TBL] [Abstract][Full Text] [Related]
10. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor. Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879 [TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367 [TBL] [Abstract][Full Text] [Related]
13. Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal Cancer. Hall MD; Schultheiss TE; Smith DD; Fakih MG; Kim J; Wong JY; Chen YJ Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S580-7. PubMed ID: 25956577 [TBL] [Abstract][Full Text] [Related]
14. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663 [TBL] [Abstract][Full Text] [Related]
15. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement. Sprenger T; Rothe H; Becker H; Beissbarth T; Homayounfar K; Gauss K; Kitz J; Wolff H; Scheel AH; Ghadimi M; Rödel C; Conradi LC; Liersch T Am J Surg Pathol; 2013 Aug; 37(8):1283-9. PubMed ID: 23851331 [TBL] [Abstract][Full Text] [Related]
16. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy]. Thomschke D; Kyau-Ummen B; Halbfass HJ Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499 [TBL] [Abstract][Full Text] [Related]
17. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322 [TBL] [Abstract][Full Text] [Related]
18. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261 [TBL] [Abstract][Full Text] [Related]
19. The role of lymphadenectomy in cervical cancer patients: the significance of the number and the status of lymph nodes removed in 526 cases treated in a single institution. Ditto A; Martinelli F; Lo Vullo S; Reato C; Solima E; Carcangiu M; Haeusler E; Mariani L; Lorusso D; Raspagliesi F Ann Surg Oncol; 2013 Nov; 20(12):3948-54. PubMed ID: 23812772 [TBL] [Abstract][Full Text] [Related]
20. Less than 12 nodes in the surgical specimen after total mesorectal excision following neoadjuvant chemoradiation: it means more than you think! de Campos-Lobato LF; Stocchi L; de Sousa JB; Buta M; Lavery IC; Fazio VW; Dietz DW; Kalady MF Ann Surg Oncol; 2013 Oct; 20(11):3398-406. PubMed ID: 23812804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]